There are 2867 resources available
LBA27 - Additional analyses of MOUNTAINEER: A phase II study of tucatinib and trastuzumab for HER2-positive mCRC
Presenter: John Strickler
Session: Mini Oral session: GI, lower digestive
Resources:
Abstract
Slides
Webcast
Alternative cell therapies
Presenter: Ulrike Kohl
Session: Cellular therapies for solid tumours
Resources:
Slides
Webcast
Invited Discussant LBA68 and LBA73
Presenter: Laurence Albiges
Session: Proffered Paper session 2: GU tumours, non-prostate
Resources:
Slides
Webcast
Invited Discussant 650O and 651O
Presenter: Amanda Psyrri
Session: Proffered Paper session: Head & neck cancer
Resources:
Slides
Webcast
Invited Discussant LBA26 and LBA27
Presenter: Per Pfeiffer
Session: Mini Oral session: GI, lower digestive
Resources:
Slides
Webcast
Pushing the limit of detection for minimal residual disease
Presenter: Maximilian Diehn
Session: Creating a new stage between early and metastatic cancers: Illustration with lung cancers
Resources:
Slides
Webcast
Invited Discussant 623MO and 624MO
Presenter: Irit Avivi
Session: Mini Oral session: Haematological malignancies
Resources:
Slides
Webcast
933MO - Longitudinal monitoring of circulating tumor DNA from plasma in patients with curative resected stage IA-IIIA EGFR mutant non-small cell lung cancer
Presenter: Myung-Ju Ahn
Session: Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1486MO - The synovial and systemic pharmacokinetics and pharmacodynamics of intra-articular administration of the CSF1 receptor antibody AMB-05X in a phase II proof-of-concept trial in tenosynovial giant cell tumor
Presenter: Hans Gelderblom
Session: Mini Oral session: Sarcoma
Resources:
Abstract
Slides
Webcast
Discussion
Presenter: All Speakers
Session: Cellular therapies for solid tumours
Resources:
Webcast